Localization of apolipoprotein E in normal and atherosclerotic human aorta
Vladimir R. Babaev(Vanderbilt University Medical Center), В. Н. Смирнов(Academy of Medical Sciences), E. V. Yanushevskaya(Academy of Medical Sciences), Alexander D. Dergunov(Academy of Medical Sciences), Alexander A. Chenchik(Academy of Medical Sciences), Ilya Trakht(Academy of Medical Sciences), Edvard M. Tararak(Academy of Medical Sciences), Clemens Sorg(Hautklinik Heidelberg)
Cited by 19
Related Papers
Treatment of diabetes and atherosclerosis by inhibiting fatty-acid-binding protein aP2
|Nature|2007|732
Lack of macrophage fatty-acid–binding protein aP2 protects mice deficient in apolipoprotein E against atherosclerosis
|Nature Medicine|2001|692
Reducing endoplasmic reticulum stress through a macrophage lipid chaperone alleviates atherosclerosis
|Nature Medicine|2009|482
Increased atherosclerosis in mice reconstituted with apolipoprotein E null macrophages
|Proceedings of the National Academy of Sciences|1997|289
Akt Signaling in Macrophage Polarization, Survival, and Atherosclerosis
|International Journal of Molecular Sciences|2019|283